355 related articles for article (PubMed ID: 25669980)
21. The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review.
Chen Q; Zhong T
Drug Des Devel Ther; 2015; 9():5115-22. PubMed ID: 26379424
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.
Zhang C; Li J; Han Y; Jiang J
Drug Des Devel Ther; 2015; 9():3267-78. PubMed ID: 26150700
[TBL] [Abstract][Full Text] [Related]
23. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer.
Schimanski CC; Schwald S; Simiantonaki N; Jayasinghe C; Gönner U; Wilsberg V; Junginger T; Berger MR; Galle PR; Moehler M
Clin Cancer Res; 2005 Mar; 11(5):1743-50. PubMed ID: 15755995
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological significance of CXCR4 in non-small cell lung cancer.
Zhou XM; He L; Hou G; Jiang B; Wang YH; Zhao L
Drug Des Devel Ther; 2015; 9():1349-58. PubMed ID: 25834393
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of CXCR4 in acute myeloid leukemia.
Ahn JY; Seo K; Weinberg OK; Arber DA
Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):79-84. PubMed ID: 22914607
[TBL] [Abstract][Full Text] [Related]
26. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
27. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
Lin SC; Gan ZH; Yao Y; Min da L
PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
[TBL] [Abstract][Full Text] [Related]
28. The chemokine receptor CXCR4 as a novel independent prognostic marker for node-positive breast cancer patients.
Parker CC; Kim RH; Li BD; Chu QD
J Surg Oncol; 2012 Sep; 106(4):393-8. PubMed ID: 22473623
[TBL] [Abstract][Full Text] [Related]
29. High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome.
Chu QD; Panu L; Holm NT; Li BD; Johnson LW; Zhang S
J Surg Res; 2010 Apr; 159(2):689-95. PubMed ID: 19500800
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Significance of CXCR4 in Colorectal Cancer: An Updated Meta-Analysis and Critical Appraisal.
Ottaiano A; Santorsola M; Del Prete P; Perri F; Scala S; Caraglia M; Nasti G
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209026
[No Abstract] [Full Text] [Related]
31. CXCR4 membrane expression in node-negative breast cancer.
Blot E; Laberge-Le Couteulx S; Jamali H; Cornic M; Guillemet C; Duval C; Hellot MF; Pille JY; Picquenot JM; Veyret C
Breast J; 2008; 14(3):268-74. PubMed ID: 18373506
[TBL] [Abstract][Full Text] [Related]
32. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
Holm NT; Abreo F; Johnson LW; Li BD; Chu QD
Breast Cancer Res Treat; 2009 Jan; 113(2):293-9. PubMed ID: 18270814
[TBL] [Abstract][Full Text] [Related]
33. CXCR4 expression in early breast cancer and risk of distant recurrence.
Andre F; Xia W; Conforti R; Wei Y; Boulet T; Tomasic G; Spielmann M; Zoubir M; Berrada N; Arriagada R; Hortobagyi GN; Hung MC; Pusztai L; Delaloge S; Michiels S; Cristofanilli M
Oncologist; 2009 Dec; 14(12):1182-8. PubMed ID: 19939894
[TBL] [Abstract][Full Text] [Related]
34. Expression of molecular factors correlated with metastasis in small cell lung cancer and their significance.
Li XX; Li RJ; Zhao LJ; Liu NB; Wang P
Int J Clin Exp Pathol; 2015; 8(11):14676-84. PubMed ID: 26823791
[TBL] [Abstract][Full Text] [Related]
35. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma.
Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ
Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128
[TBL] [Abstract][Full Text] [Related]
36. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.
Wagner PL; Hyjek E; Vazquez MF; Meherally D; Liu YF; Chadwick PA; Rengifo T; Sica GL; Port JL; Lee PC; Paul S; Altorki NK; Saqi A
J Thorac Cardiovasc Surg; 2009 Mar; 137(3):615-21. PubMed ID: 19258077
[TBL] [Abstract][Full Text] [Related]
37. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
38. Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer.
Akashi T; Koizumi K; Tsuneyama K; Saiki I; Takano Y; Fuse H
Cancer Sci; 2008 Mar; 99(3):539-42. PubMed ID: 18201276
[TBL] [Abstract][Full Text] [Related]
39. The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions.
Davidson B; Dong HP; Holth A; Berner A; Risberg B
Breast J; 2008; 14(5):476-82. PubMed ID: 18657145
[TBL] [Abstract][Full Text] [Related]
40. The prognostic implication of slug in all tumour patients - a systematic meta-analysis.
Huang C; Zhang P; Zhang D; Weng X
Eur J Clin Invest; 2016 May; 46(5):398-407. PubMed ID: 26919035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]